Orrum’s CŌRE Insights™ analytics platform will be available through an automatic integration for LivaNova’s Essenz Perfusion System PLYMOUTH, Mich., Feb. 20, 2026Orrum’s CŌRE Insights™ analytics platform will be available through an automatic integration for LivaNova’s Essenz Perfusion System PLYMOUTH, Mich., Feb. 20, 2026

Orrum Announces Strategic Partnership with LivaNova to Unite Intelligent Data with Innovative Perfusion Technology

2026/02/20 21:32
3 min read

Orrum’s CŌRE Insights™ analytics platform will be available through an automatic integration for LivaNova’s Essenz Perfusion System

PLYMOUTH, Mich., Feb. 20, 2026 /PRNewswire/ — Orrum Clinical Analytics today announced a strategic partnership with LivaNova USA Inc. to connect LivaNova’s Essenz™ Perfusion System to the analytics and benchmarking capabilities of Orrum’s CŌRE Insights™ platform.

Designed for patient management during cardiopulmonary bypass, the Essenz Perfusion System (Essenz) features advanced tools to support data-driven care, including Quality Indicators and Goal-Directed Perfusion. Through this strategic partnership, Orrum and LivaNova are introducing CoreInsights for Essenz, empowering clinicians to make more confident decisions, while advancing safety, quality, and data literacy across perfusion and extracorporeal care.

Through this collaboration, perfusion case data from the Essenz database can be safely and automatically transferred to Orrum’s analytics platform for post-operative analysis and peer benchmarking, supporting evidence-based performance improvement. Through this integration, CoreInsights for Essenz can extend the value of perfusion data beyond the operating room, supporting meaningful pre- and post-operative analytics across the full patient care continuum.

Built within a secure, legally privileged Patient Safety Organization (PSO) recognized by the U.S. Department of Health & Human Services, Orrum’s platform integrates curated advanced data visualizations, powerful analytics, peer benchmarking, and non-routine safety event reporting to deliver actionable insights that clinicians can trust.

CoreInsights for Essenz can provide perfusion teams with:

  • Automatic, continuous data capture and submission for improved accuracy and workflow
  • Curated, clinically relevant analytics to measure adherence to hospital and national benchmarks
  • Actionable, timely insights for perfusionists on practice patterns and key performance indicators

“Our collaboration with LivaNova is rooted in a shared objective: empowering clinicians, elevating patient outcomes, and inspiring innovation that reaches far beyond the operating room,” said Sean Murtha, CEO of Orrum. “At our core, Orrum is committed to advancing clinical quality, safety, and excellence. Through this integration, we are transforming clinical data into clear, decision-ready insights and ushering in a new era of analytics in cardiac surgery with CoreInsights for Essenz.”

To learn more, visit orrum.com/core-insights/.

About Orrum Clinical Analytics

Orrum Clinical Analytics is a clinical intelligence hub designed to support how healthcare teams use data to advance quality and safety. Built within a secure, legally privileged Patient Safety Organization (PSO) recognized by the U.S. Department of Health & Human Services, Orrum integrates advanced data visualizations, analytics, peer benchmarking, and non-routine safety event reporting to support higher standards of performance across perfusion and extracorporeal care. For more information, please visit orrum.com.

MEDIA CONTACT:
Sean Murtha / Orrum / 833-313-DATA (3282)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/orrum-announces-strategic-partnership-with-livanova-to-unite-intelligent-data-with-innovative-perfusion-technology-302693084.html

SOURCE Orrum Clinical Analytics

Market Opportunity
Unite Logo
Unite Price(UNITE)
$0,00008896
$0,00008896$0,00008896
+%0,22
USD
Unite (UNITE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Supreme Court Strikes Down Most of Donald Trump Tariffs

Supreme Court Strikes Down Most of Donald Trump Tariffs

TL;DR Court rules IEEPA does not authorize presidential tariff powers. Decision invalidates reciprocal and fentanyl-linked tariffs. Steel and aluminum tariffs under
Share
Coincentral2026/02/21 00:15
Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

The post Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC appeared on BitcoinEthereumNews.com. Franklin Templeton CEO Jenny Johnson has weighed in on whether the Federal Reserve should make a 25 basis points (bps) Fed rate cut or 50 bps cut. This comes ahead of the Fed decision today at today’s FOMC meeting, with the market pricing in a 25 bps cut. Bitcoin and the broader crypto market are currently trading flat ahead of the rate cut decision. Franklin Templeton CEO Weighs In On Potential FOMC Decision In a CNBC interview, Jenny Johnson said that she expects the Fed to make a 25 bps cut today instead of a 50 bps cut. She acknowledged the jobs data, which suggested that the labor market is weakening. However, she noted that this data is backward-looking, indicating that it doesn’t show the current state of the economy. She alluded to the wage growth, which she remarked is an indication of a robust labor market. She added that retail sales are up and that consumers are still spending, despite inflation being sticky at 3%, which makes a case for why the FOMC should opt against a 50-basis-point Fed rate cut. In line with this, the Franklin Templeton CEO said that she would go with a 25 bps rate cut if she were Jerome Powell. She remarked that the Fed still has the October and December FOMC meetings to make further cuts if the incoming data warrants it. Johnson also asserted that the data show a robust economy. However, she noted that there can’t be an argument for no Fed rate cut since Powell already signaled at Jackson Hole that they were likely to lower interest rates at this meeting due to concerns over a weakening labor market. Notably, her comment comes as experts argue for both sides on why the Fed should make a 25 bps cut or…
Share
BitcoinEthereumNews2025/09/18 00:36
Top Crypto to Watch Before Q2 2026: IPO Genie ($IPO) Building Early Hype

Top Crypto to Watch Before Q2 2026: IPO Genie ($IPO) Building Early Hype

Most presale buyers do not fail because they picked the “wrong token.” In fact, they fail because they wait until the early window is gone. That single delay is
Share
CryptoReporter2026/02/20 23:51